Literature DB >> 30667319

Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.

Brainner Campos Barbosa1, Edson Marchiori2, Caio Leal Leidersnaider3, Lara Brandao3, Mauricio Castillo4.   

Abstract

Tumefactive demyelinating lesions are a rare disorder in which inflammatory demyelination manifests as solitary or multiple focal brain lesions (greater than 2 cm in size), which can be mistaken for glioma, lymphoma, metastasis and in some cases even brain abscess. The symptomatology of tumefactive demyelinating lesions depends on the white matter area involved and includes quickly progressing neurological deterioration of motor, sensory and visual function, praxis, language and mood impairment, as well as seizures. Recognising the key imaging features in a patient with a prior history of demyelination may expedite appropriate management. Preoperative diagnosis or at least the consideration of a demyelinating process is important to avoid unnecessary surgery. We report three patients with demyelinating lesions who presented with findings suggestive of demyelination on conventional magnetic resonance imaging studies. However, in all patients the lesions showed high perfusion and in two high permeability, which are findings generally seen with high-grade neoplasias. In rare instances, tumefactive demyelinating lesions may show increased perfusion and high permeability, imaging findings more commonly seen in high-grade gliomas. We suggest that if white matter lesions on conventional magnetic resonance imaging are compatible with tumefactive demyelinating lesions, atypical findings of high perfusion/permeability should not dissuade the radiologist from suggesting the presence of tumefactive demyelinating lesions rather than high-grade gliomas.

Entities:  

Keywords:  MRI; Tumefactive demyelinating lesions; high-grade gliomas; perfusion; permeability

Mesh:

Year:  2019        PMID: 30667319      PMCID: PMC6410458          DOI: 10.1177/1971400919826394

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  16 in total

Review 1.  The MRI appearance of tumefactive demyelinating lesions.

Authors:  Curtis A Given; B Scott Stevens; Charles Lee
Journal:  AJR Am J Roentgenol       Date:  2004-01       Impact factor: 3.959

2.  Differentiation of tumefactive demyelinating lesions from high-grade gliomas with the use of diffusion tensor imaging.

Authors:  C H Toh; K-C Wei; S-H Ng; Y-L Wan; M Castillo; C-P Lin
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

Review 3.  Update on brain tumor imaging: from anatomy to physiology.

Authors:  S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

4.  Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.

Authors:  H S Malhotra; K K Jain; A Agarwal; M K Singh; S K Yadav; M Husain; N Krishnani; R K Gupta
Journal:  Mult Scler       Date:  2009-02       Impact factor: 6.312

5.  Case Series: tumefactive demyelinating lesions: a diagnostic challenge.

Authors:  Aria Fallah; Sarfaraz Banglawala; Shanil Ebrahim; John E Paulseth; Neilank K Jha
Journal:  Can J Surg       Date:  2010-02       Impact factor: 2.089

6.  Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.

Authors:  S Cha; S Pierce; E A Knopp; G Johnson; C Yang; A Ton; A W Litt; D Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

7.  Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction.

Authors:  R Haselhorst; L Kappos; D Bilecen; K Scheffler; D Möri; E W Radü; J Seelig
Journal:  J Magn Reson Imaging       Date:  2000-05       Impact factor: 4.813

8.  Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.

Authors:  A Cianfoni; S Niku; S G Imbesi
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

9.  Adult brain tumors: clinical applications of magnetic resonance spectroscopy.

Authors:  Lara A Brandão; Mauricio Castillo
Journal:  Neuroimaging Clin N Am       Date:  2013-05-10       Impact factor: 2.264

10.  Abnormalities of cerebral perfusion in multiple sclerosis.

Authors:  W Rashid; L M Parkes; G T Ingle; D T Chard; A T Toosy; D R Altmann; M R Symms; P S Tofts; A J Thompson; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

View more
  3 in total

Review 1.  Differential imaging of atypical demyelinating lesions of the central nervous system.

Authors:  Matteo Paoletti; Shaun Ivan Muzic; Francesca Marchetti; Lisa Maria Farina; Stefano Bastianello; Anna Pichiecchio
Journal:  Radiol Med       Date:  2021-01-24       Impact factor: 3.469

2.  Magnetic Resonance Imaging and Clinical Features of the Demyelinating Degeneration of White Matter in Young Patients.

Authors:  Jian Li; Yi-Ming Zhao
Journal:  Int J Gen Med       Date:  2021-07-05

3.  Clinical manifestations and imaging features of white matter demyelination in older patients.

Authors:  Jian Li; Yi-Ming Zhao
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.